HMGB2 and posterior cortical atrophy: The role of HMGB2 in PCa has been less studied than that of HMGB1, and, as deduced from our in vitro experiments with PCa cell lines, its differential regulatory role in aggressive types of PCa is of interest for the selection of more specific therapeutic targets, which can allow new therapies to be developed for these patients.